Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Unlike older GH-releasing peptides (GHRPs), Ipamorelin is highly selective
The information provided here is based on the details made available by the manufacturer and may not reflect our independent views or endorsements
baseline Ipamorelin (Via GHS-R1a): Ghrelin receptor agonism in the pituitary/hypothalamus Synergy with GHRH: potentiates GH release 3-5x Somatostatin Inhibition (GHIH): Tonic Unlocking Pulse frequency: Physiological periodicity maintenance Selectivity: no cortisol effects (vs GHRP-2/6) Combined Pharmacokinetics: GH Liberation Profile: Pico GH: 90-120 minutes post combination administration Magnitude: 5-10x baseline levels (dose-dependent) Lift duration: 4-6 hours Secondary IGF-1: sustained increase 24-48h Applications, Mechanisms, and Extended Research 1
USE within 6 months of opening
US$ 21.55
US$ 21.94
US$ 21.26
US$ 29.44
